{"disease":{"id":"hypoplasminogenemia","name":"hypoplasminogenemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02690714","title":"A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Prometic Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT03642691","title":"A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Prometic Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT03265171","title":"A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Prometic Biotherapeutics, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}